Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate plus glucocorticoid versus glucocorticoid alone for bullous pemphigoid
ChiCTR-TRC-12003593Phase 4Completed
- Sponsor
- St John's Institute of Dermatology
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Bullous Pemphigoid (BP) comparing Glucocorticoids group with Glucocorticoid plus MTX group (2 arms). Primary endpoints: Pemphigoid antibodies titer, Glucocorticoid dosage and 2 more. Started Jan 2011; status: completed.
02
Drugs
methotrexateprednisone
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on ChiCTR-TRC-12003593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003593.